These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 9872012)
1. [New approaches for encapsulation of peptides into poly(lactic/glycolic acid) microspheres]. Blanco-Prieto MJ; Fattal E; Puisieux F; Couvreur P Ann Pharm Fr; 1998; 56(6):256-63. PubMed ID: 9872012 [TBL] [Abstract][Full Text] [Related]
2. Multiple emulsion technology for the design of microspheres containing peptides and oligopeptides. Fattal E; Roques B; Puisieux F; Blanco-Prieto MJ; Couvreur P Adv Drug Deliv Rev; 1997 Oct; 28(1):85-96. PubMed ID: 10837566 [TBL] [Abstract][Full Text] [Related]
3. Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method. Leo E; Pecquet S; Rojas J; Couvreur P; Fattal E J Microencapsul; 1998; 15(4):421-30. PubMed ID: 9651864 [TBL] [Abstract][Full Text] [Related]
4. Influence of formulation variables on the in-vitro release of albumin from biodegradable microparticulate systems. Igartua M; Hernández RM; Esquisabel A; Gascon AR; Calvo MB; Pedraz JL J Microencapsul; 1997; 14(3):349-56. PubMed ID: 9147284 [TBL] [Abstract][Full Text] [Related]
5. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287 [TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of PLGA microspheres containing a staphylokinase variant (K35R). He JT; Tao XM; Mo W; Song HY Yao Xue Xue Bao; 2006 Jan; 41(1):12-8. PubMed ID: 16683521 [TBL] [Abstract][Full Text] [Related]
7. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954 [TBL] [Abstract][Full Text] [Related]
8. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies. Gavini E; Chetoni P; Cossu M; Alvarez MG; Saettone MF; Giunchedi P Eur J Pharm Biopharm; 2004 Mar; 57(2):207-12. PubMed ID: 15018976 [TBL] [Abstract][Full Text] [Related]
9. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination. Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180 [TBL] [Abstract][Full Text] [Related]
10. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres. He JT; Su HB; Li GP; Tao XM; Mo W; Song HY Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979 [TBL] [Abstract][Full Text] [Related]
11. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles. Kumar PS; Ramakrishna S; Saini TR; Diwan PV Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069 [TBL] [Abstract][Full Text] [Related]
12. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery. Díez S; Tros de Ilarduya C Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172 [TBL] [Abstract][Full Text] [Related]
13. In vitro ciprofloxacin release from poly(lactide-co-glycolide) microspheres. Martinez B; Lairion F; Pena MB; Di Rocco P; Nacucchio MC J Microencapsul; 1997; 14(2):155-61. PubMed ID: 9132467 [TBL] [Abstract][Full Text] [Related]
14. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study. Dhanaraju MD; Rajkannan R; Selvaraj D; Jayakumar R; Vamsadhara C Contraception; 2006 Aug; 74(2):148-56. PubMed ID: 16860053 [TBL] [Abstract][Full Text] [Related]
15. Insulin nanoparticle preparation and encapsulation into poly(lactic-co-glycolic acid) microspheres by using an anhydrous system. Han Y; Tian H; He P; Chen X; Jing X Int J Pharm; 2009 Aug; 378(1-2):159-66. PubMed ID: 19465100 [TBL] [Abstract][Full Text] [Related]
16. Formulation and in vitro/in vivo evaluation of terbutaline sulphate incorporated in PLGA (25/75) and L-PLA microspheres. Selek H; Sahin S; Ercan MT; Sargon M; Hincal AA; Kas HS J Microencapsul; 2003; 20(2):261-71. PubMed ID: 12554379 [TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification. Gasparini G; Kosvintsev SR; Stillwell MT; Holdich RG Colloids Surf B Biointerfaces; 2008 Feb; 61(2):199-207. PubMed ID: 17919891 [TBL] [Abstract][Full Text] [Related]
18. Morphology and release kinetics of technetium-99m(V) dimercaptosuccinic acid loaded, poly(lactic-co-glycolic)acid microspheric delivery system. An experimental approach that may be used for targeted radiation treatment. Shukla J; Bandopadhyaya GP; Varma IK; Kumar R; Maulik SK Hell J Nucl Med; 2007; 10(1):9-13. PubMed ID: 17450243 [TBL] [Abstract][Full Text] [Related]
19. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release. Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022 [TBL] [Abstract][Full Text] [Related]
20. Gentamicin-loaded discs and microspheres and their modifications: characterization and in vitro release. Naraharisetti PK; Lew MD; Fu YC; Lee DJ; Wang CH J Control Release; 2005 Feb; 102(2):345-59. PubMed ID: 15653156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]